Navigation Links
New Species of Coral Discovered Off Southern California

A working group of virologists headed by Professor Hans-Georg Kräusslich at Heidelberg University Hospitals, jointly with Professor Hanswalter Zentgraf, Division of Applied Tumor Virology of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), have been the first to label Human Immunodeficiency Viruses (HIV) for visual investigations without inhibiting the functional characteristics of the virus.

The labeling permits scientists to observe the behavior of the virus when it enters a host cell, during replication and when it leaves a cell. This is a major step towards understanding the process of HIV infection.

Modern imaging technologies facilitate real-time observation of virus-cell interactions. Many of these investigation methods require labeling of the object of interest, such as by introducing the genetic code of green fluorescent protein (GFP) into its genetic information. There the marker protein will be produced by the cellular machinery and appended to the desired site.

To observe the interaction of HIV with the host cell, there had also been attempts to label the virus with GFP. However, the genetic modifications impaired the formation of virus particles or their infectiousness, thus limiting the value of results obtained. A team of Heidelberg researchers of the university hospitals?Virology Section and the DKFZ have now found an area within the structure molecule of the viral capsid that tolerates the substantial extension by GFP. Although the insertion of the GFP molecule enlarges the HIV structure protein by about one half, infectious viruses continue to be generated. Using electron microscopy, Zentgraf’s team was able to show that appearance and shape of the virus particles thus created cannot be distinguished from normal HIV. By simultaneous production of GFP-extended and normal structure protein, PD Dr. Barbara Müller was able to produce, under a fluorescence microscope, clearly visible HIVs with several th
'"/>

Source:


Page: 1 2

Related biology news :

1. New Clues Add 40,000 Years to Age of Human Species
2. Ants Genetic Engineering Leads To Species Interdependency
3. A New Species of Monkey is Discovered in Tanzania: The First in Africa for More Than 20 Years
4. Species unique to tidal marshes face threats
5. Corals switch skeleton material as seawater changes
6. Coral reefs are increasingly vulnerable to angry oceans
7. Coral stress like never in history
8. Corals that can fight global warming may one day help fragile reefs
9. Corals -- More complex than you?
10. Newly Discovered Compound Blocks Known Cancer-Causing Protein
11. Same-Sex Mating Discovered in a Toxic Fungus

Post Your Comments:
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
(Date:11/24/2009)...and the American College of Medical Toxicology (AC... publication of the Journal of Medical Toxicology...ng in March 2010. It was previously published by ...urnal of Medical Toxicology , an international, pe... science and practice of medical toxicology. The ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3American Joint Replacement Registry Announced 52562 1American Joint Replacement Registry Announced 52562 2
...entified a key signaling molecule in the brain tha...g for cocaine. Their finding could offer an import...ircuiting that adaptive process. , In an article i...o Bonci and colleagues established that a short pr... region central to the adaptation to addictive dru...
...s shed more light on the multi-decade debate about...ng at them. , You don,t have to watch your legs an...are. For decades scientists have debated two optio...flow hypothesis says that the brain monitors signa...ly to contract, and uses this to predict where the...
...d "peak fish" and fishermen,s nets will be hauling...l action to stem the global tide of over fishing, ... British Columbia. Dr. Daniel Pauly says the crisi...c proof than about attitude and political will. ,...gh-profile political champion like a Bono or Mande...
Other Biology News:How the brain learns to become addicted 2How does the brain know what the right hand is doing? 2Hooked on fishing, and we're heading for the bottom, says scientist 2Hooked on fishing, and we're heading for the bottom, says scientist 3
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced the approval of all of its,"f... the District of Delaware,(the "Bankruptcy Court")...relief under Chapter 11 of the United States Bankr...he orders issued by the Bankruptcy Court allow the...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
(Date:11/24/2009)...imary efficacy endpoint has been met for patients ...ancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fir...SX: AEZ) (the "Company"), a global biopharmaceutic...gy, today announced positive efficacy data from a ...conjugate, AEZS-108 (formerly AN-152), in patients...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...TON BEACH, California, and AMSTERDAM, May 28 ,Agen...s, today announced its,strong support of Genentech...ocket No. FDA-2008-P-0638-0001/CP petitions that a... scientific and regulatory standards. In response,...er of support to the U.S.,Food and Drug Administra...
...France, May 28 Poxel is a research integrated,pha...erono a division of,Merck KGaA, Germany, following...in diabetes research and development. It aims to a...ses (with a primary focus on Type 2,diabetes) from...fore,out-licensing these projects to major pharmac...
...G, Md., May 28 GenVec, Inc. (Nasdaq: GNVC ) a... agreement with a single institutional investor fo... and warrants to purchase 9,615,385 shares of its ...ants are being offered in units consisting of one ...e share of common stock at a price of $0.624 per u...
Other Biology Technology:Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards 2Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 3
...yacrylamide gel electrophoresis (2D-PAGE) with bio...core technology platform for proteomic analysis. 2... complex samples limited only in the dynamic range...Quantitative image based analysis of separated pro...
LabWorks Analysis Software from UVP
...apor Trap Models RVT100, RVT400, RVT405DDA, RVT410... UVS400A and UVS800DDA., A non-corrosive, odorles...or use for temperatures ranging from -105 to +260 ...ability and does not evaporate. Far superior to dr...
... is a concentrated formulation of a rinsing buffer...n technology, as well as for manual immunostaining...gati M.D., Department of Pathology, University of ...ended for all the rinsing steps performed when doi...
Biology Products: